JPMorgan Chase & Co’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.06M | Sell |
234,801
-188,999
| -45% | -$3.27M | ﹤0.01% | 2846 |
|
|
2025
Q1 | $9.27M | Buy |
423,800
+12,251
| +3% | +$268K | ﹤0.01% | 2241 |
|
|
2024
Q4 | $13.1M | Sell |
411,549
-3,473,181
| -89% | -$111M | ﹤0.01% | 2038 |
|
|
2024
Q3 | $112M | Buy |
3,884,730
+707,260
| +22% | +$20.4M | 0.01% | 833 |
|
|
2024
Q2 | $122M | Buy |
3,177,470
+963,161
| +43% | +$36.9M | 0.01% | 769 |
|
|
2024
Q1 | $130M | Sell |
2,214,309
-359,824
| -14% | -$21.2M | 0.01% | 763 |
|
|
2023
Q4 | $154M | Buy |
2,574,133
+356,386
| +16% | +$21.3M | 0.01% | 649 |
|
|
2023
Q3 | $84.4M | Buy |
2,217,747
+430,765
| +24% | +$16.4M | 0.01% | 808 |
|
|
2023
Q2 | $163M | Buy |
1,786,982
+138,530
| +8% | +$12.6M | 0.02% | 597 |
|
|
2023
Q1 | $109M | Sell |
1,648,452
-198,857
| -11% | -$13.1M | 0.01% | 703 |
|
|
2022
Q4 | $95.5M | Buy |
1,847,309
+907,262
| +97% | +$46.9M | 0.01% | 720 |
|
|
2022
Q3 | $64.2M | Sell |
940,047
-133,918
| -12% | -$9.15M | 0.01% | 852 |
|
|
2022
Q2 | $48.6M | Sell |
1,073,965
-192,273
| -15% | -$8.69M | 0.01% | 971 |
|
|
2022
Q1 | $64.3M | Sell |
1,266,238
-321,640
| -20% | -$16.3M | 0.01% | 958 |
|
|
2021
Q4 | $75.1M | Buy |
1,587,878
+54,736
| +4% | +$2.59M | 0.01% | 918 |
|
|
2021
Q3 | $50.5M | Buy |
1,533,142
+1,118,049
| +269% | +$36.9M | 0.01% | 1074 |
|
|
2021
Q2 | $26.2M | Sell |
415,093
-21,187
| -5% | -$1.34M | ﹤0.01% | 1431 |
|
|
2021
Q1 | $18.7M | Sell |
436,280
-195,352
| -31% | -$8.38M | ﹤0.01% | 1648 |
|
|
2020
Q4 | $36.1M | Sell |
631,632
-71,773
| -10% | -$4.11M | 0.01% | 1120 |
|
|
2020
Q3 | $20.3M | Buy |
703,405
+602,266
| +595% | +$17.4M | ﹤0.01% | 1313 |
|
|
2020
Q2 | $3.3M | Buy |
101,139
+24,304
| +32% | +$794K | ﹤0.01% | 2411 |
|
|
2020
Q1 | $2.06M | Sell |
76,835
-350,211
| -82% | -$9.38M | ﹤0.01% | 2582 |
|
|
2019
Q4 | $13.1M | Buy |
427,046
+411,200
| +2,595% | +$12.6M | ﹤0.01% | 1601 |
|
|
2019
Q3 | $382K | Buy |
15,846
+2,570
| +19% | +$62K | ﹤0.01% | 3454 |
|
|
2019
Q2 | $325K | Buy |
13,276
+4,465
| +51% | +$109K | ﹤0.01% | 3555 |
|
|
2019
Q1 | $172K | Sell |
8,811
-414
| -4% | -$8.08K | ﹤0.01% | 3817 |
|
|
2018
Q4 | $122K | Buy |
9,225
+860
| +10% | +$11.4K | ﹤0.01% | 3972 |
|
|
2018
Q3 | $149K | Sell |
8,365
-47,376
| -85% | -$844K | ﹤0.01% | 3972 |
|
|
2018
Q2 | $1.23M | Buy |
55,741
+53,514
| +2,403% | +$1.18M | ﹤0.01% | 3039 |
|
|
2018
Q1 | $49K | Sell |
2,227
-108
| -5% | -$2.38K | ﹤0.01% | 4150 |
|
|
2017
Q4 | $51K | Buy |
+2,335
| New | +$51K | ﹤0.01% | 4125 |
|